CUREMOX-LB 625
CUREMOX-LB 625 is a powerful broad-spectrum antibiotic combination of Amoxicillin (500mg) and Potassium Clavulanate (125mg), enriched with Lactic Acid Bacillus. It is specifically designed to treat various bacterial infections while maintaining a healthy gut balance, effectively preventing antibiotic-induced diarrhea.
Description
CUREMOX-LB 625 Tablets offer a comprehensive approach to fighting bacterial infections. This “Gold Standard” antibiotic therapy combines the strength of a penicillin-type antibiotic with a beta-lactamase inhibitor, ensuring it remains effective even against resistant bacteria.
Advanced Triple-Action Formula:
-
Amoxicillin (500mg): A robust antibiotic that works by preventing the growth of bacteria, effectively clearing the infection from the body.
-
Potassium Clavulanate (125mg): Many bacteria produce an enzyme called beta-lactamase that can deactivate antibiotics. Potassium Clavulanate blocks this enzyme, allowing the Amoxicillin to do its job effectively.
-
Lactic Acid Bacillus (60 Million Spores): Antibiotics can often kill “good” bacteria in the gut, leading to side effects like diarrhea or indigestion. The addition of Lactic Acid Bacillus restores the natural flora of the digestive system for a smoother recovery.
Key Therapeutic Indications:
-
Respiratory Tract Infections: Including pneumonia, bronchitis, and sinusitis.
-
ENT Infections: Effective for tonsillitis and otitis media (middle ear infections).
-
Urinary Tract Infections (UTI): Targets bacteria affecting the bladder and kidneys.
-
Skin & Soft Tissue Infections: Treats abscesses, cellulitis, and wound infections.
-
Dental Infections: Often prescribed for severe dental abscesses.
Usage & Safety Information:
-
Dosage: As directed by a healthcare professional. It is usually recommended to take this medication with food to enhance absorption and reduce stomach upset.
-
Storage: Store in a cool, dry place, away from direct sunlight.
-
Important Note: Always complete the full course prescribed by your doctor to prevent the development of antibiotic resistance.





